Brief: China Resources Pharmaceutical Group Posts FY Revenue For Jiangzhong Pharmaceutical RMB3.81 Bln
March 27 (Reuters) - China Resources Pharmaceutical
Group Ltd 3320.HK :
* FY NET PROFIT ATTRIBUTABLE FOR JIANGZHONG PHARMACEUTICAL
RMB596.1 MILLION VERSUS RMB505.7 MILLION
* FY REVENUE FOR JIANGZHONG PHARMACEUTICAL RMB3.81 BILLION
VERSUS
RMB 2.87 BILLION
Source text for Eikon: ID:nHKS6Nhmwv
Further company coverage: 3320.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million